|
SNHG4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.206570E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.317600E-02 |
| Normal-vs-Stage2 |
2.375000E-01 |
| Normal-vs-Stage3 |
1.600240E-01 |
| Normal-vs-Stage4 |
4.428800E-01 |
| Stage1-vs-Stage2 |
6.766600E-01 |
| Stage1-vs-Stage3 |
6.788200E-01 |
| Stage1-vs-Stage4 |
6.171800E-01 |
| Stage2-vs-Stage3 |
9.214400E-01 |
| Stage2-vs-Stage4 |
8.259600E-01 |
| Stage3-vs-Stage4 |
7.580200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.310970E-01 |
| Normal-vs-AfricanAmerican |
1.949890E-02 |
| Normal-vs-Asian |
1.851160E-01 |
| Caucasian-vs-AfricanAmerican |
8.066400E-02 |
| Caucasian-vs-Asian |
9.959800E-01 |
| AfricanAmerican-vs-Asian |
1.895990E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.258040E-01 |
| Normal-vs-Female |
1.304450E-01 |
| Male-vs-Female |
8.484000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.162040E-01 |
| Normal-vs-Age(41-60Yrs) |
7.936200E-02 |
| Normal-vs-Age(61-80Yrs) |
5.690800E-01 |
| Normal-vs-Age(81-100Yrs) |
9.374300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.000600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.324200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.793400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.498200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.452000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.753200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.217200E-01 |
| Classical-VS-Follicular |
1.978030E-01 |
| Classical-VS-Other |
4.157600E-04 |
| Classical-VS-Normal |
2.137800E-01 |
| Tall-VS-Follicular |
5.182000E-01 |
| Tall-VS-Other |
3.962900E-03 |
| Tall-VS-Normal |
1.916800E-01 |
| Follicular-VS-Other |
1.318100E-02 |
| Follicular-VS-Normal |
7.009800E-02 |
| Other-VS-Normal |
6.369800E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.096000E-01 |
| Normal-vs-N1 |
4.032800E-01 |
| N0-vs-N1 |
7.188800E-01 |
|
|
